The Bolt-On Tax: What Australia's New Merger Regime Means for Specialty Retail Roll-Ups.

For a decade, the fastest way to build scale in fragmented Australian specialty retail was simple. Buy a platform, then quietly stitch on smaller competitors one at a time, deal by deal, largely below the regulator's line of sight. That era ended on 1 January 2026.

Australia has moved from a voluntary, informal merger clearance system to a mandatory and suspensory regime administered by the Australian Competition and Consumer Commission. According to Squire Patton Boggs, transactions that meet the monetary thresholds cannot complete until the ACCC grants clearance or a waiver, full stop. There is no more asking forgiveness after the fact. In its first three months alone, the regime generated 50 merger notifications and 108 waiver applications, according to Innovera Partners, a pace that shows how broadly the new rules are already biting into mid-market dealmaking that never used to touch a regulator's desk.

Why serial acquirers should pay attention

The mechanism that matters most for buy-and-build investors is the three-year cumulative turnover test. A single $15 million bolt-on might sail under the radar on its own. But according to Gilbert + Tobin, the ACCC will now look back three years and add up all acquisitions of substitutable goods or services by the same buyer, meaning a platform's entire roll-up history can trigger mandatory notification on what looks like a modest, routine deal. Buyers are already being asked in due diligence to disclose every prior transaction touching the same category and whether it was notified to the ACCC.

This is not a theoretical concern confined to supermarkets and telcos. Gilbert + Tobin reports that the ACCC chair has explicitly flagged liquor, pathology and private cancer radiation chains as sectors under close watch, while the Assistant Minister for Competition has pointed to serial acquisitions in childcare, aged care, and dentistry as emerging competition hotspots. The direction of travel is clear: regulators are naming private equity roll-ups by name, not retail specifically, but the underlying playbook of platform-plus-bolt-ons is the exact strategy specialty retail buyers have used for years in categories like pet care, optical, liquor, and beauty retail.

The cost side compounds the friction. A rejected exemption request can add an $8,300 filing fee before a single dollar of legal work is done, and a Phase 2 review can run to a fixed $475,000, according to CDI Global. For a sub-$50 million bolt-on, that is a meaningful hit to deal economics, and CDI Global's analysis suggests it may push some buyers to lower the multiples they are willing to pay, or to exit the small-mid M&A market altogether rather than absorb the compliance burden.

The counterintuitive part

Here is where we think the market narrative gets it backwards. The instinct is to treat this as bad news for buy-and-build. We would argue the opposite, at least for the right kind of buyer.

Regulatory friction does not kill roll-up strategies. It kills undisciplined ones. The operators who treated bolt-ons as a volume game, moving fast, skipping structured integration, relying on the old system's inattention, are the ones who now face real transaction risk. Every deal has to be considered in the context of everything that came before it, which means a buyer's acquisition history is now a live strategic asset or liability, not a closed chapter.

For a patient, sector-focused lower mid-market investor, that is a genuine advantage. A platform built with disciplined pacing, clean documentation, and a defensible competitive rationale for each bolt-on will move through notification and waiver processes with far less friction than a platform that has been assembled opportunistically. PwC Australia frames 2026 as a year of cautious optimism for private capital generally, and notes the reforms are explicitly designed to bring more structure and certainty to competitive review, not to shut the door on consolidation.

There is a second-order effect worth naming plainly, without pretending it is settled fact. Higher compliance costs on small deals could compress the pool of active bolt-on buyers over time, particularly opportunistic or thinly-capitalised acquirers who cannot absorb a $475,000 Phase 2 bill on a $20 million deal. If that plays out, it should, over time, reduce competitive tension for well-capitalised, process-literate buyers chasing the same founder-owned specialty retail targets. That is a forecast, not a guarantee, and it assumes the ACCC's early enforcement posture holds rather than softens.

What this means for founders and platforms

For founders in specialty retail sitting on a business that might eventually roll into a larger platform, the practical implication is timing and documentation, not fear. Buyers doing serious due diligence will now ask harder questions about a target's own acquisition history and category positioning, and a founder who can answer those questions cleanly will move faster through a process that has genuinely gotten slower for everyone else.

For platform operators and co-investors, the lesson is to build the three-year transaction ledger now, before it is needed under deal pressure, and to treat competition analysis as a day-one part of deal feasibility rather than a late-stage legal formality. The buy-and-build thesis in Australian specialty retail has not weakened. It has simply started rewarding the operators who were disciplined about it all along.

Let's talk

If your specialty retail business is weighing where it sits in a consolidating category, or you are building a platform and want a second read on where the regulatory line now falls, we would welcome the conversation.

Sources

 

This article is provided for general informational purposes only and does not constitute financial, investment, legal or tax advice, nor an offer, solicitation or recommendation in respect of any security, fund or transaction. Views expressed are those of Astra Capital Proprietary Limited ACN 691553849 at the time of publication and may change without notice. Information sourced from third parties is believed to be reliable but has not been independently verified and no warranty is given as to its accuracy or completeness. Past performance and industry trends are not indicative of future results. Readers should seek independent professional advice before making any investment decision. © Astra Capital Proprietary Limited ACN 691553849. All rights reserved.

 

Back to blog

© 2026 Astra Capital Asset Management Pty Ltd (ACN 627 079 574) & Astra Capital Asset Management (Singapore) Pte Ltd UEN 202605889H · All rights reserved.

Astra Capital Licensing & Compliance Pty Ltd (ACN 683 665 296) is the holder of Australian Financial Services Licence 700095.

The information on this website is general in nature and does not constitute financial product advice; it does not take into account your objectives, financial situation or needs and should not be relied upon as a substitute for professional advice.

Privacy Policy · Terms of Use